LENTIVECTOR
USPTO Trademark Record · Serial No. 86538703
Trademark details
It was initially claimed by Oxford BioMedica plc on 20150218.
That brand applies to the following goods and services:(Based on Intent to Use) (Based on 44(e)) Chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations, (Based on Intent to Use) (Based on 44(e)) Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing retroviral vector preparations and/or nucleic acid suitable for gene therapy; retroviral vector preparations for use in gene therapy; pharmaceutical preparations containing a retroviral vector delivering genes to cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS, neurodegenerative, (Based on Intent to Use) Material treatment, namely, chemical synthesis for others featuring the development of a process to manufacture ingredients or finished biochemical products for applications in biotechnology and gene therapy, (Based on Intent to Use) (Based on 44(e)) Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology.
Currently that trademark is represented by trademark attorney(s): Roberta S. Bren.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the LENTIVECTOR trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
